ADVANCES IN THE MANAGEMENT OF ULCERATIVE COLITIS

PFIZER, S.A

Objeto

Topic: Gastroenterology.

Destination: This competitive grant program seeks to improve healthcare professional understanding of Sphingosine-1-phosphate (S1P) receptor modulation in the treatment of UC. Projects that will be considered for Pfizer support will focus on providing education to healthcare professionals (HCPs) involved in diagnosis, treatment, and management of patients with UC.

Budget: Up to $150,000/project.

Duration: Up to 3 years.

Are you interested in this call?

Estás interesado?

Llena el siguiente formulario para recibir más información: